Skip to content

Drug interactions

Memantine-donepezil + Pasireotide

Severity: Moderate

Memantine-donepezil and Pasireotide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pasireotide and donepezil can each prolong the QT interval, and pasireotide also causes bradycardia, which donepezil may worsen. Together they raise the risk of arrhythmia.

What this interaction means in plain words

Memantine-donepezil and Pasireotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Memantine-donepezil belongs to Central Nervous System; Pasireotide belongs to Endocrine.

Evidence level: Moderate

Why it happens

Additive QT prolongation, with additive bradycardia from vagotonic donepezil and pasireotide.

What to do

Obtain a baseline ECG and monitor it during therapy, and correct potassium and magnesium. Monitor heart rate and watch for syncope.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Memantine-donepezil and Pasireotide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Memantine-donepezil with Pasireotide?

MediHelp rates the interaction as moderate. Memantine-donepezil and Pasireotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Pasireotide and donepezil can each prolong the QT interval, and pasireotide also causes bradycardia, which donepezil may worsen. Together they raise the risk of arrhythmia.

How serious is the interaction between Memantine-donepezil and Pasireotide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and monitor it during therapy, and correct potassium and magnesium. Monitor heart rate and watch for syncope.

What other medicines interact with Memantine-donepezil?

MediHelp also lists interactions of Memantine-donepezil with, for example, Dronedarone, Thioridazine, Amantadine. The full list is on the Memantine-donepezil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in